In Smokin’, I talked about how, when I was 10 years old, I willed myself to become the Marlboro Man. A reader was kind enough to respond with, “Dude! You left me hanging there at the end. Did you ...
Arcadia Consumer Healthcare Inc, which is backed by Avista Capital Partners, has acquired anti-diarrheal medicine Kaopectate from Sanofi. No financial terms were disclosed. NEW YORK, March 20, 2020 ...
The maker of the popular anti-diarrhea medicine Kaopectate has agreed to reduce levels of toxic lead in its product as part of a settlement with state Attorney General Bill Lockyer. The state sued ...
NEW YORK, March 20, 2020 /PRNewswire/ -- Arcadia Consumer Healthcare, Inc., (formerly Kramer Laboratories, Inc.) a recognized leader in the consumer healthcare industry, today announced that is has ...
The makers of Kaopectate agreed Thursday to reformulate all of its popular antidiarrhea products so they no longer contain potentially harmful levels of lead. A Superior Court judge in San Francisco ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The maker of ...
Environmentalists, consumer groups and state Attorney General Bill Lockyer called the settlement a victory for children, who can suffer brain damage even from low levels of lead. "Hundreds of ...
KAOPECTATE LIQUID prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.
It acquires five former Pfizer brands in a J&J divestiture move.
Addressing a potential health threat in a product millions of parents have given their children, the maker of the anti-diarrhea medicine Kaopectate agreed to slash its lead levels in a settlement with ...
Bismuth subsalicylate 262mg/15mL; regular (contains K+ 5mg, Na+ 10mg), peppermint (contains K+ 5mg, Na+ 10mg), and cherry flavor (contains Na+ 10mg).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results